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Background:  Bone marrow derived progenitor cells have been suggested to promote postnatal neovascularization, therefore providing a potential 
therapeutic option for ischemic diseases. In this study we investigated whether direct intramuscular infusion of enriched hematopoietic cells, 
improved limb perfusion in a murine model of hind limb ischemia.
Methods:  Wild type C57BL/6 male mice underwent unilateral hind-limb ischemia, were divided in three groups (n=12/group) and received a 
single intramuscular injection of 1x106 Lin-/sca+ cells, or granulocyte colony-stimulating factor (G-CSF) for 7 days or normal saline. Each group 
Mice underwent laser Doppler perfusion imaging after surgery on days 0, 7 and 28 for the estimation of the bilateral hind-limb perfusion. Muscle 
tissue sections were stained with rat anti-CD31antibody. Capillaries and arterioles in the ischemic areas were counted with confocal microscopy at 
day 28.
Results:  Ischemic/non ischemic ratio was significantly increased in ischemic limbs of cell- and G-CSF-treated mice versus control mice at 7 
days (p<0.05 vs control), which was maintained at 28 days (p<0.05 vs control) only in the cell-treated group. There was no significant increase of 
ischemic/nonischemic ratio in the cell-treated mice compared with G-CSF at day 7 or day 28 (p=NS). Capillary density was increased in the cell-
treated group compared to G-CSF-treated group and control (2.67±0.44 vs 1.6±0.39 vs 0.71±0.59 cap/cm2 p<0.05). No difference in the capillary 
density between the G-CSF-treated and the control group was observed.
Conclusion: Direct intramuscular infusion of lin-/sca+ significantly improved blood flow and vasculogenesis compared with G-CSF and saline 
treatment. Direct intramuscular infusion of bone marrow derived or endothelial progenitor cells but not cell mobilization with G-CSF increased blood 
flow and vasculogenesis in a murine model of limb ischemia.
